Silver Book Fact

From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical life-year.

The Expanding Pharmaceutical Arsenal in the War on Cancer. NBER Working Paper Series Web site. http://www.nber.org/papers/w10328. Published 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
NBER Working Paper Series
Publication Date
Published 2004
Authors
Lichtenberg, F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • Medicines in Devlopment for Cancer, 2008  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine currently in development may delay the worsening of liver cancer. The medicine is an oral signal transduction inhibitor…  
  • Since Congress passed the National Cancer Act in 1971, the percentage of the U.S. population living with, through, or beyond a cancer diagnosis has more than tripled.  
  • If the use of recommended colorectal screening increased to 70.5 percent, 1,000 additional lives could be saved each year.